Skip to main content

Table 1 Characteristics of patients with RA patients and Healthy controls (HCs)

From: The proportion and phenotypic changes of CD4+CD25−Foxp3+ T cells in patients with untreated rheumatoid arthritis

Clinical variables

RA patients (n = 61)

HCs (n = 40)

Sex, female/male (n)

51/10

37/3

Age, years mean ± SEM

43.15 ± 15.46

44.68 ± 13.39

Disease duration, months

10 (4–36)

 

ESR, mm/h

27 (16–41.5)

 

CRP, mg/l

6.95 (3.20–17.4)

 

DAS28-ESR

4.39 (2.83–5.58)

 

DAS28-CRP

3.64 (3.01–4.92)

 

Tender joint count

6 (3.5–15)

 

Swollen joint count

7.5 (2.75–17.5)

 

Anti-CCP, IU/ml

21.9 (0.63–266.9)

 

Anti-CCP, positivity

50/61 (82.0%)

 

RF, IU/ml

27.5 (12.0–160.8)

 

RF, positivity

43/61 (70.5%)

 
  1. All the data were demonstrated as median [IQR, 25th–75th percentile]
  2. RA, rheumatoid arthritis; DAS28-ESR, Disease Activity Score in 28 joints using the erythrocyte sedimentation rate; CRP, C-reactive protein; RF, rheumatoid factor; anti-CCP, anti-cyclic citrullinated peptide
Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us